BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38711049)

  • 1. Molecular interactions between metformin and D-limonene inhibit proliferation and promote apoptosis in breast and liver cancer cells.
    Salim EI; Alabasy MM; Nashar EME; Al-Zahrani NS; Alzahrani MA; Guo Z; Beltagy DM; Shahen M
    BMC Complement Med Ther; 2024 May; 24(1):185. PubMed ID: 38711049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with metformin and IL-12 to inhibit the growth of hepatic carcinoma by promoting apoptosis and autophagy in HepG2-bearing mice.
    Jin Z; Jia BX; Tan LD; Chen QM; Liu YH
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12368-12379. PubMed ID: 33336757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic inhibitory effect of berberine and d-limonene on human gastric carcinoma cell line MGC803.
    Zhang XZ; Wang L; Liu DW; Tang GY; Zhang HY
    J Med Food; 2014 Sep; 17(9):955-62. PubMed ID: 25045784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proliferation inhibition and apoptosis induction of K562 cells by D-limonene].
    Gao D; Xiao Z; Lü AE
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1120-2. PubMed ID: 17204176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A High-throughput Quantitative Expression Analysis of Cancer-related Genes in Human HepG2 Cells in Response to Limonene, a Potential Anticancer Agent.
    Hafidh RR; Hussein SZ; MalAllah MQ; Abdulamir AS; Abu Bakar F
    Curr Cancer Drug Targets; 2018; 18(8):807-815. PubMed ID: 29141549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiabetic drug metformin induces apoptosis in human MCF breast cancer via targeting ERK signaling.
    Malki A; Youssef A
    Oncol Res; 2011; 19(6):275-85. PubMed ID: 21776823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Epothilone A in Combination with the Antidiabetic Drugs Metformin and Sitagliptin in HepG2 Human Hepatocellular Cancer Cells: Role of Transcriptional Factors NF-κB and p53.
    Rogalska A; Sliwinska A; Kasznicki J; Drzewoski J; Marczak A
    Asian Pac J Cancer Prev; 2016; 17(3):993-1001. PubMed ID: 27039825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
    Liu H; Scholz C; Zang C; Schefe JH; Habbel P; Regierer AC; Schulz CO; Possinger K; Eucker J
    Anticancer Res; 2012 May; 32(5):1627-37. PubMed ID: 22593441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early LC3 lipidation induced by d-limonene does not rely on mTOR inhibition, ERK activation and ROS production and it is associated with reduced clonogenic capacity of SH-SY5Y neuroblastoma cells.
    Berliocchi L; Chiappini C; Adornetto A; Gentile D; Cerri S; Russo R; Bagetta G; Corasaniti MT
    Phytomedicine; 2018 Feb; 40():98-105. PubMed ID: 29496180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lily polysaccharide 1 enhances the effect of metformin on proliferation and apoptosis of human breast carcinoma cells].
    Hou J; Li F; Li X; Mei Q; Mi M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):780-3. PubMed ID: 27371846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of apoptosis by D-limonene is mediated by inactivation of Akt in LS174T human colon cancer cells.
    Jia SS; Xi GP; Zhang M; Chen YB; Lei B; Dong XS; Yang YM
    Oncol Rep; 2013 Jan; 29(1):349-54. PubMed ID: 23117412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy between sublethal doses of shikonin and metformin fully inhibits breast cancer cell migration and reverses epithelial-mesenchymal transition.
    Tabari AR; Gavidel P; Sabouni F; Gardaneh M
    Mol Biol Rep; 2022 Jun; 49(6):4307-4319. PubMed ID: 35525887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of tamoxifen and D-limonene enhances therapeutic efficacy in breast cancer cells.
    Mandal D; Sahu BR; Parija T
    Med Oncol; 2023 Jun; 40(8):216. PubMed ID: 37391551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the mevalonate pathway and cell growth by pravastatin and d-limonene in a human hepatoma cell line (Hep G2).
    Kawata S; Nagase T; Yamasaki E; Ishiguro H; Matsuzawa Y
    Br J Cancer; 1994 Jun; 69(6):1015-20. PubMed ID: 8198962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of D-limonene on leukemia cells HL-60 and K562 in vitro].
    Guo XM; Lu Q; Liu ZJ; Wang LF; Feng BA
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Aug; 14(4):692-5. PubMed ID: 16928301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma.
    Ma J; Guo Y; Chen S; Zhong C; Xue Y; Zhang Y; Lai X; Wei Y; Yu S; Zhang J; Liu W
    BMC Cancer; 2014 Mar; 14():172. PubMed ID: 24612549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limonene terpenoid obstructs human bladder cancer cell (T24 cell line) growth by inducing cellular apoptosis, caspase activation, G2/M phase cell cycle arrest and stops cancer metastasis.
    Ye Z; Liang Z; Mi Q; Guo Y
    J BUON; 2020; 25(1):280-285. PubMed ID: 32277643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formononetin and metformin act synergistically to inhibit growth of MCF-7 breast cancer cells in vitro.
    Xin M; Wang Y; Ren Q; Guo Y
    Biomed Pharmacother; 2019 Jan; 109():2084-2089. PubMed ID: 30551465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between anticancer effect of metformin and the transcriptional regulation of certain genes (CHOP, CAV-1, HO-1, SGK-1 and Par-4) on MCF-7 cell line.
    Salis O; Bedir A; Ozdemir T; Okuyucu A; Alacam H
    Eur Rev Med Pharmacol Sci; 2014 Jun; 18(11):1602-9. PubMed ID: 24943970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin inhibits human breast cancer cell growth by promoting apoptosis via a ROS-independent pathway involving mitochondrial dysfunction: pivotal role of superoxide dismutase (SOD).
    Sharma P; Kumar S
    Cell Oncol (Dordr); 2018 Dec; 41(6):637-650. PubMed ID: 30088260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.